Cargando…
Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma
Protein tyrosine phosphatase receptor-type Z (PTPRZ) is aberrantly over-expressed in glioblastoma and a causative factor for its malignancy. However, small molecules that selectively inhibit the catalytic activity of PTPRZ have not been discovered. We herein performed an in vitro screening of a chem...
Autores principales: | Fujikawa, Akihiro, Nagahira, Asako, Sugawara, Hajime, Ishii, Kentaro, Imajo, Seiichi, Matsumoto, Masahito, Kuboyama, Kazuya, Suzuki, Ryoko, Tanga, Naomi, Noda, Masanori, Uchiyama, Susumu, Tomoo, Toshiyuki, Ogata, Atsuto, Masumura, Makoto, Noda, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746629/ https://www.ncbi.nlm.nih.gov/pubmed/26857455 http://dx.doi.org/10.1038/srep20473 |
Ejemplares similares
-
Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
por: Fujikawa, Akihiro, et al.
Publicado: (2017) -
Specific Dephosphorylation at Tyr-554 of Git1 by Ptprz Promotes Its Association with Paxillin and Hic-5
por: Fujikawa, Akihiro, et al.
Publicado: (2015) -
Behavioral and neurological analyses of adult mice carrying null and distinct loss-of-receptor function mutations in protein tyrosine phosphatase receptor type Z (PTPRZ)
por: Tanga, Naomi, et al.
Publicado: (2019) -
Protein Tyrosine Phosphatase Receptor Type Z Negatively Regulates Oligodendrocyte Differentiation and Myelination
por: Kuboyama, Kazuya, et al.
Publicado: (2012) -
Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation
por: Kuboyama, Kazuya, et al.
Publicado: (2017)